Incidence and Severity of Hand–Foot Syndrome in Colorectal Cancer Patients Treated with Capecitabine: A Single-Institution Experience
- 1 January 2002
- journal article
- clinical trial
- Published by Taylor & Francis in Cancer Investigation
- Vol. 20 (1) , 3-10
- https://doi.org/10.1081/cnv-120000360
Abstract
Background: Hand–foot syndrome (HFS) has been previously reported as a side effect in 45–56% of patients treated with capecitabine. However, the natural history of HFS has not been fully characteri...Keywords
This publication has 21 references indexed in Scilit:
- Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast CancerJournal of Clinical Oncology, 1999
- CapecitabineDrugs, 1999
- Pyridoxine Therapy for Palmar-Plantar Erythrodysesthesia Associated With TaxotereJNCI Journal of the National Cancer Institute, 1993
- Chemotherapy-induced acral erythemaJournal of the American Academy of Dermatology, 1991
- Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusionInvestigational New Drugs, 1990
- Pyroxidine for the Palmar-Plantar Erythrodysesthesia SyndromeAnnals of Internal Medicine, 1989
- Palmar-Plantar Skin Changes and CytarabineAnnals of Internal Medicine, 1985
- Cancer Chemotherapy and Skin ChangesAnnals of Internal Medicine, 1985
- Peculiar Acral Erythema Secondary to High-Dose Chemotherapy for Acute Myelogenous LeukemiaAnnals of Internal Medicine, 1982
- Vitamin B6 and Skin Lesions in RatsNature, 1939